Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors

Autor: Stephen R. Cole, Meredith G. Warshaw, Penpact (Penta ), Christina Ludema, Pactg Study Team, Carol E. Golin, Ross E. McKinney, Dwight E. Yin, William C. Miller

Publikováno v: PLoS ONE
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
PLoS ONE, Vol 15, Iss 11, p e0242405 (2020)

Background Choice of initial antiretroviral therapy regimen may help children with HIV maintain optimal, continuous therapy. We assessed treatment-naïve children for differences in time to treatment disruption across randomly-assigned protease inhib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::411fe2aaad97f87332e8a460c05e3442
https://pubmed.ncbi.nlm.nih.gov/33226999